ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced (LA) squamous cell carcinoma of the head and neck (HNSCC)

被引：2
|
作者：
Forster, M. [1 ]
Mendes, R. [1 ]
Urbano, T. Guerrero [2 ]
Evans, M. [3 ,4 ]
Lei, M. [2 ]
Spanswick, V. [5 ]
Miles, E. [6 ]
Simoes, R. [6 ]
Wheeler, G. [7 ]
Forsyth, S. [8 ]
White, L. [8 ]
机构：
[1] Univ Coll London Hosp, Dept Oncol, London, England
[2] Guys & St Thomas Hosp, Dept Oncol, London, England
[3] Univ Hosp Wales UHW, Velindre Canc Ctr, Cardiff, Wales
[4] Vale Univ Hlth Board CVUHB, NHS Wales, Cardiff, Wales
[5] UCL Canc Inst, UCL ECMC GCLP Facil, London, England
[6] Mt Vernon Canc Ctr, Radiotherapy Trials Qual Assurance RTTQA Grp, Radiotherapy Phys, Northwood, Middx, England
[7] Imperial Coll London, Imperial Clin Trials Unit, London, England
[8] UCL, CR UK & UCL Canc Trials Ctr, London, England
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1276
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
866P
引用
收藏
页码：S789 / S790
页数：2
相关论文
共 50 条
  • [1] ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck.
    Forster, Martin David
    Mendes, Ruheena
    Harrington, Kevin J.
    Urbano, Teresa Guerrero
    Baines, Helen
    Spanswick, Victoria J.
    Ensell, Leah
    Hartley, John A.
    Adeleke, Sola
    Gougis, Paul
    Leader, David
    McDowell, Cathy
    Lopes, Andre
    Teague, Jonathan
    Forsyth, Sharon
    Beare, Sandy
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck
    Day, D.
    Prawira, A.
    Spreafico, A.
    Waldron, J.
    Karithanam, R.
    Giuliani, M.
    Weinreb, I
    Kim, J.
    Cho, J.
    Hope, A.
    Bayley, A.
    Ringash, J.
    Bratman, S., V
    Jang, R.
    O'Sullivan, B.
    Siu, L. L.
    Hansen, A. R.
    ORAL ONCOLOGY, 2020, 108
  • [3] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, J. G.
    Kim, D. H.
    Sohn, S. K.
    Baek, J. H.
    Chae, Y. S.
    Lee, K. B.
    Sohn, J. H.
    Park, J. S.
    Kim, J. C.
    Park, I. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 300 - 300
  • [4] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    J G Kim
    S K Sohn
    D H Kim
    J H Baek
    S B Jeon
    Y S Chae
    K B Lee
    J S Park
    J H Sohn
    J C Kim
    I K Park
    British Journal of Cancer, 2005, 93 : 1117 - 1121
  • [5] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Jeon, SB
    Chae, YS
    Lee, KB
    Park, JS
    Sohn, JH
    Kim, JC
    Park, IK
    BRITISH JOURNAL OF CANCER, 2005, 93 (10) : 1117 - 1121
  • [6] Phase II trial of valproic acid combined with cisplatin-based chemoradiation in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) patients (pts).
    Mak, Milena Perez
    Pasini, Fatima Solange
    Diao, Lixia
    Garcia, Fabyane Oliveira Teixeira
    Takahashi, Tiago Kenji
    Amadio, Alex Vitorio
    Siqueira, Sheila Aparecida Coelho
    Sichero, Laura
    Snitcovsky, Igor M. L.
    Kulcsar, Marco Aurelio Vamondes
    Wang, Jing
    Castro, Gilberto
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Cisplatin-based concomitant chemoradiotherapy in locally advanced squamous cell carcinoma of head and neck: toxicity and feasibility analysis
    Atasoy, Beste Melek
    Dane, Faysal
    Sari, Murat
    Akgun, Zuleyha
    Yumuk, Perran Fulden
    Turhal, Nam Serdar
    Abacioalu, Ufuk
    Sengor, Meric
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2008, 23 (01): : 1 - 11
  • [8] EFFICACY OF CONCURRENT CHEMORADIOTHERAPY WITH CAPECITABINE AND CISPLATIN IN THE MANAGEMENT OF LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Gupta, S.
    Khan, H.
    Barik, S.
    Negi, M. P. S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S2 - S2
  • [9] Efficacy and safety of concurrent chemoradiotherapy (CCR) for unresectable locally advanced (ULA) head and neck squamous cell carcinoma (HNSCC).
    Castro, G
    Snitcovsky, IML
    Gebrim, EM
    Leitao, GM
    Rocha, CN
    Nadalin, W
    Ferraz, AR
    Federico, MHH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 522S - 522S
  • [10] Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    H Katori
    M Tsukuda
    I Mochimatu
    J Ishitoya
    S Kawai
    Y Mikami
    H Matsuda
    Y Tanigaki
    C Horiuchi
    Y Ikeda
    T Taguchi
    M Ono
    T Yoshida
    S Hirose
    Y Sakuma
    K Yamamoto
    British Journal of Cancer, 2004, 90 : 348 - 352
12345